SCHEMBL8374491

SCHEMBL8374491

CCOC(=O)/C(C)=C/c1ccc(Oc2cccnc2)c(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 5/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
HSP90AA1 P07900 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
CYP1A2 P05177 1/20 0.37
HTR2B P41595 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374493 1.00 MEN1 (0.46) MEN1POLBKMT2AMAPTSMN1; SMN2
SCHEMBL8374897 0.87 TBXAS1 (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL8438436 0.87 TBXAS1 (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
Guanidine SCHEMBL8518148 0.82 SMN1; SMN2 (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL10988022 0.81 MAPT (0.49) MEN1POLBKMT2AMAPTSMN1; SMN2
SCHEMBL10988025 0.81 MAPT (0.49) MEN1POLBKMT2AMAPTSMN1; SMN2
SCHEMBL8374500 0.75 MAPT (0.46) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL8374503 0.75 MAPT (0.46) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL2420053 0.74 MAPT (0.53) MEN1POLBKMT2AMAPTSMN1; SMN2
SCHEMBL2420056 0.74 MAPT (0.53) MEN1POLBKMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755919-B1 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them HOECHST AG (DE) 1999-11-17 EP disclosed
US-5883133-A CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-16 US disclosed
EP-0755919-A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-01-29 EP disclosed